Prostate cancer. Who is best benefited by external beam radiation therapy?
The major indications for radical radiation therapy of prostate cancer for both early-stage and locally advanced disease are discussed. Important issues in the interpretation of long-term treatment series are reviewed. The outcomes of therapy are analyzed for both early-stage and locally advanced disease, including alternative therapeutic strategies. On the basis of this review of the literature, current treatment recommendations delineate patients most likely to benefit from radiation therapy as opposed to alternative therapeutic modalities.
Hartford
A C
AC
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Zietman
A L
AL
D015982:Bias; D003627:Data Interpretation, Statistical; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D018579:Patient Selection; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D015996:Survival Rate; D016896:Treatment Outcome